Ligand Pharmaceuticals, Inc. (LGND)
189.17
+5.52
(+3.01%)
USD |
NASDAQ |
Feb 24, 16:00
189.17
0.00 (0.00%)
After-Hours: 17:02
Ligand Pharmaceuticals Research and Development Expense (Quarterly) : 21.02M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 3.992B |
| ADMA Biologics, Inc. | 1.528M |
| Johnson & Johnson | 4.268B |
| Elanco Animal Health, Inc. | 89.00M |
| Ionis Pharmaceuticals, Inc. | 217.13M |